查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2087948

鬱血性心臟衰竭治療設備市場：按設備類型、治療方法、最終用戶和分銷管道分類－2026-2032年全球市場預測

Congestive Heart Failure Treatment Device Market by Device Type, Therapeutic Modality, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，鬱血性心臟衰竭設備的市場規模將成長至 603.5 億美元，複合年成長率為 16.29%。

主要市場統計數據
基準年 2025 209.8億美元
預計年份：2026年 243億美元
預測年份 2032 603.5億美元
複合年成長率 (%) 16.29%

用於治療鬱血性心臟衰竭（CHF）的醫療器材市場概覽

隨著人口老化、高血壓、糖尿病、缺血性心臟疾病、慢性腎臟病以及心血管事件後存活率的提高，心臟衰竭的負擔日益加重，治療鬱血性（ CHF）的器械在心血管治療中扮演著至關重要的角色。醫療設備領域涵蓋心臟再同步治療（CRT）、植入式心臟整流去顫器（ICD）、心室輔助裝置（VAD）、植入式和穿戴式血流動力學監測系統、超過濾技術、遠端患者監護平台以及出院後管理工具。

心臟衰竭（CHF）器材護理的變革性變化

充血性心臟衰竭（CHF）治療設備的格局正在從間歇性干預轉向數據驅動的持續性疾病管理。醫院在評估設備時，不僅關注其操作性能，還越來越重視其在支持時間序列監測、藥物最佳化、減少補償事件、加強早期護理和提高生活品質方面的能力。

人工智慧（AI）的累積影響

人工智慧 (AI) 正在加速心臟衰竭治療從被動治療轉向預測性治療的轉變。 AI 驅動的分析整合了來自醫療設備的遙測數據、體重、血壓、心率數據、活動趨勢、實驗室檢查結果、用藥史和電子健康記錄信息，以便在症狀惡化並需要緊急醫療救助之前識別疾病進展的風險。

區域性心臟衰竭治療設備的關鍵見解。

北美地區仍然是心臟衰竭治療器材的主要市場，這得益於其較高的心臟衰竭診斷率、先進的電生理和心臟衰竭診療項目、醫療保險覆蓋範圍、便捷的專科醫生資源，以及植入式監測和機械循環支持設備的早期應用。歐洲受益於完善的心臟器械報銷系統、強大的臨床研究網路和歐盟統一的監管政策，但成本控制壓力、衛生技術評估 (HTA) 要求和採購審查正在影響醫院對這些器械的採用。

針對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的關鍵群體特定見解

在東協地區，私人醫療保健的擴張、醫療旅遊中心的興建、都市區循環系統中心的建設以及政府加強慢性病管理的舉措，正推動著充血性心臟衰竭（CHF）治療設備的普及。然而，報銷機制的不統一和專科醫生分佈不均阻礙了設備的全面推廣。在海灣合作理事會（GCC）國家，對專業循環系統中心、國家數位醫療系統和先進醫院基礎設施的投資正在穩步推進，遠端監測、高階植入式設備以及針對嚴重心臟衰竭的治療方案在區域醫療服務中發揮著至關重要的作用。

主要國家引進心臟衰竭治療設備的趨勢

美國是創新和保險報銷的最大推動力，ICD、CRT、遠端監護和VAD等設備得到廣泛應用，這得益於先進的心臟衰竭中心以及公共和私人保險公司的全面覆蓋。加拿大強調實證醫療和省級報銷，而墨西哥和巴西則因私人心血管護理的擴張和慢性病負擔的加重，成為拉丁美洲的關鍵成長市場。在英國、德國、法國、義大利和西班牙，先進的心臟中心、統一的國家指南和完善的電生理服務維持市場需求，但預算審查和技術評估流程正在影響採購週期。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床驗證的差異化優勢，特別是那些能夠減少心臟衰竭住院次數、支持遠端系統管理、改善功能狀態並與基於指南的藥物治療相結合的器械。循證策略應包括對真實世界結果、衛生經濟學終點、亞組性能和耐用性數據、安全性監測以及臨床醫生、看護者和患者易用性的深入分析。

調查方法

本執行摘要基於二手研究，參考了公共衛生機構、同行評審的心血管文獻、臨床實踐指南、法規結構、報銷標準、醫院技術評估材料以及醫療設備業報告。資訊來源包括世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國心臟協會/美國心臟病學會/美國心臟和纖維安全管理局 (AHA/ACC/HFSA)、歐洲心臟病學會 (ESC)、美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 等權威機構，以及適用的國家衛生部門。

結論

充血性心臟衰竭（CHF）治療設備市場正朝著整合式、智慧化的心臟照護方向發展，將植入、監測、分析和臨床工作流程連結起來。這項技術的廣泛應用取決於它能否證明其能夠減少住院次數、改善功能狀態、提供更安全的長期支持、提高設備耐用性和經濟永續性。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：鬱血性心臟衰竭器材市場：依器械類型分類

  • 心臟再同步治療裝置
  • 植入式心臟整流去顫器
  • 心室輔助裝置
    • 雙心室輔助裝置
    • 左心室輔助裝置
    • 右心室輔助裝置

第8章：鬱血性心臟衰竭器材市場：依治療方式分類

  • 電刺激
    • 非同步心律調節器
    • 同步心律調節器
  • 機械循環輔助

第9章：鬱血性心臟衰竭設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第10章：鬱血性心臟衰竭治療器械市場：依分銷管道分類

  • 直銷
  • 銷售代理
  • 線上銷售

第11章鬱血性心臟衰竭器材市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：鬱血性心臟衰竭治療器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章：鬱血性心臟衰竭治療器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Abbott Laboratories
  • Abiomed, Inc.
  • Ancora Heart, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardiacAssist, Inc.
  • Cook Medical LLC
  • CorWave SA
  • CVRx, Inc.
  • Edwards Lifesciences Corporation
  • Getinge AB
  • Jarvik Heart Inc.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • MEDICO SpA
  • Medtronic plc
  • MicroPort Scientific Corporation
  • OSCOR Inc.
  • Osypka Medical GmbH
  • Otsuka Pharmaceutical Co., Ltd.
  • ReliantHeart, Inc.
  • Shree Pacetronix Ltd.
  • SynCardia Systems LLC
  • Terumo Corporation
  • Vitatron BV
  • WL Gore & Associates, Inc.
  • Zoll Medical Corporation
Product Code: MRR-036CEF508588

The Congestive Heart Failure Treatment Device Market is projected to grow by USD 60.35 billion at a CAGR of 16.29% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 20.98 billion
Estimated Year [2026] USD 24.30 billion
Forecast Year [2032] USD 60.35 billion
CAGR (%) 16.29%

CHF Treatment Device Market Introduction

Congestive heart failure (CHF) treatment devices are becoming central to cardiovascular care as aging populations, hypertension, diabetes, ischemic heart disease, chronic kidney disease, and improved survival after cardiac events expand the heart failure burden. The device landscape spans cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), ventricular assist devices (VADs), implantable and wearable hemodynamic monitoring systems, ultrafiltration technologies, remote patient monitoring platforms, and connected post-discharge management tools.

Demand is supported by guideline-directed care, rising hospitalization costs, and payer interest in reducing preventable readmissions. The World Health Organization identifies cardiovascular disease as the leading global cause of death, while U.S. public health data show heart failure affects millions of adults and drives substantial medical spending, making CHF treatment devices a high-priority category for hospitals, payers, medtech manufacturers, and digital health innovators.

Transformative Shifts in CHF Device Care

The CHF treatment device landscape is shifting from episodic intervention toward continuous, data-enabled disease management. Hospitals increasingly evaluate devices not only by procedural performance but also by their ability to support longitudinal monitoring, medication optimization, fewer decompensation events, earlier escalation of care, and improved quality of life.

Transformative forces include miniaturized implantables, remote pulmonary artery and pressure monitoring, rechargeable and longer-life batteries, less invasive VAD implantation pathways, home-based monitoring, and value-based reimbursement. Regulatory pathways are also emphasizing real-world evidence, cybersecurity, interoperability, human factors, and post-market surveillance, raising the competitive importance of clinically validated outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is accelerating the move from reactive CHF treatment to predictive care. AI-enabled analytics can combine device telemetry, weight, blood pressure, rhythm data, activity trends, laboratory values, medication history, and electronic health record signals to identify deterioration risk before symptoms trigger an emergency visit.

Its cumulative impact is strongest where algorithms are embedded into clinician workflows rather than deployed as standalone dashboards. Validated AI can improve triage, reduce alert fatigue, personalize device programming, support advanced therapy selection, improve remote cardiac care, and strengthen population-level risk stratification, while requiring transparent validation, bias monitoring, explainability, cybersecurity safeguards, and compliance with medical device software regulations.

Key Regional Insights for CHF Treatment Devices

North America remains a leading region for CHF treatment devices due to high diagnosed heart failure prevalence, advanced electrophysiology and heart failure programs, Medicare coverage pathways, specialist access, and early adoption of implantable monitoring and mechanical circulatory support. Europe benefits from established cardiac device reimbursement, strong clinical research networks, and European Union regulatory harmonization, although cost-containment pressures, health technology assessment requirements, and procurement scrutiny shape adoption across hospitals.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in cardiac care capacity, local manufacturing, tertiary hospitals, and connected health infrastructure. Latin America shows rising demand in Brazil and Mexico, supported by private hospital networks, urban specialty care, and increasing cardiovascular risk from hypertension, diabetes, and obesity. The Middle East is investing in tertiary cardiac centers, digital health programs, and high-acuity specialty care, while Africa's opportunity is tied to access expansion, workforce training, affordable diagnostics, and scalable remote monitoring solutions for under-resourced cardiac systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

Across ASEAN, CHF device adoption is supported by expanding private healthcare, medical tourism hubs, urban cardiology centers, and government efforts to strengthen chronic disease management, although reimbursement variability and uneven specialist distribution limit uniform uptake. The GCC is investing in specialty cardiac centers, national digital health systems, and advanced hospital infrastructure, making remote monitoring, premium implantables, and high-acuity heart failure pathways relevant to regional care delivery.

The European Union provides scale through shared regulatory frameworks, strong evidence standards, and coordinated health technology assessment priorities, while BRICS countries combine large patient populations with increasing domestic medtech capacity and demand for cost-effective cardiac devices. G7 markets lead in advanced implants, VAD programs, remote monitoring integration, and evidence generation. NATO economies, many overlapping with G7 and EU members, benefit from resilient procurement systems, cybersecurity priorities, interoperable digital infrastructure, and established cardiovascular care networks for connected cardiac devices.

Key Country Insights for CHF Treatment Device Adoption

The United States is the largest innovation and reimbursement anchor, with strong uptake of ICDs, CRT, remote monitoring, and VADs supported by advanced heart failure centers and public-private payer coverage. Canada emphasizes evidence-based access and provincial reimbursement, while Mexico and Brazil are important Latin American growth markets with expanding private cardiovascular care and increasing chronic disease burden. The United Kingdom, Germany, France, Italy, and Spain sustain demand through advanced cardiac centers, national guideline alignment, and established electrophysiology services, though budget scrutiny and technology assessment processes affect purchasing cycles.

Russia remains a specialized device market influenced by localization policies and access constraints. China is scaling domestic production, tertiary cardiac care, and digital hospital infrastructure, while India is driven by high disease burden, affordability needs, and the expansion of cardiac specialty hospitals. Japan emphasizes advanced aging-related care and sophisticated implantable device management, Australia supports structured cardiac services through specialist networks, and South Korea combines digital health capability, strong hospital infrastructure, and advanced cardiovascular care adoption.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated differentiation, particularly devices that reduce heart failure hospitalization, support remote management, improve functional status, and integrate with guideline-directed medical therapy. Evidence strategies should include real-world outcomes, health economic endpoints, subgroup performance, durability data, safety surveillance, and usability findings for clinicians, caregivers, and patients.

Manufacturers should build interoperable platforms, strengthen cybersecurity, localize pricing for emerging markets, and partner with hospitals on service models that support implantation, monitoring, follow-up, and patient adherence. Commercial teams should align messaging to payers, electrophysiologists, heart failure specialists, cardiac surgeons, procurement leaders, and home-care providers, emphasizing total cost of care, workflow fit, fewer avoidable admissions, and measurable patient outcomes.

Research Methodology

This executive summary is based on secondary research from public health agencies, peer-reviewed cardiovascular literature, clinical practice guidelines, regulatory frameworks, reimbursement references, hospital technology assessment materials, and medtech industry reporting. Sources include established organizations such as WHO, CDC, AHA/ACC/HFSA, ESC, FDA, EMA, and national health authorities where applicable.

The analysis applies triangulation across disease burden, procedure trends, technology adoption, reimbursement environment, regulatory direction, clinical utility, and regional healthcare infrastructure. Insights are validated through consistency checks across epidemiology, guideline recommendations, safety evidence, post-market requirements, and procurement behavior to support reliable focused market interpretation without relying on market sizing, market share, or forecasting.

Conclusion

The CHF treatment device market is moving toward integrated, intelligence-enabled cardiac care that connects implants, monitoring, analytics, and clinical workflows. Adoption will be shaped by the ability to demonstrate fewer hospitalizations, better functional status, safer long-term support, durable device performance, and sustainable economics.

Organizations that combine robust evidence, interoperable design, AI-enabled risk detection, cybersecurity readiness, and regionally adapted access models are best positioned to address demand. As heart failure remains a major global health challenge, treatment devices will play an increasingly important role in precision cardiovascular management and long-term patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Congestive Heart Failure Treatment Device Market, by Device Type

  • 7.1. Cardiac Resynchronization Therapy Device
  • 7.2. Implantable Cardioverter Defibrillator
  • 7.3. Ventricular Assist Device
    • 7.3.1. Biventricular Assist Device
    • 7.3.2. Left Ventricular Assist Device
    • 7.3.3. Right Ventricular Assist Device

8. Congestive Heart Failure Treatment Device Market, by Therapeutic Modality

  • 8.1. Electrical Stimulation
    • 8.1.1. Asynchronous Pacemakers
    • 8.1.2. Synchronous Pacemakers
  • 8.2. Mechanical Circulatory Support

9. Congestive Heart Failure Treatment Device Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Congestive Heart Failure Treatment Device Market, by Distribution Channel

  • 10.1. Direct Sales
  • 10.2. Distributors
  • 10.3. Online Sales

11. Congestive Heart Failure Treatment Device Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Congestive Heart Failure Treatment Device Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Congestive Heart Failure Treatment Device Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Concentration Analysis, 2025
    • 14.1.1. Concentration Ratio (CR)
    • 14.1.2. Herfindahl Hirschman Index (HHI)
  • 14.2. Recent Developments & Impact Analysis, 2025
  • 14.3. Product Portfolio Analysis, 2025
  • 14.4. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Abbott Laboratories
  • 15.2. Abiomed, Inc.
  • 15.3. Ancora Heart, Inc.
  • 15.4. Berlin Heart GmbH
  • 15.5. Biotronik SE & Co. KG
  • 15.6. Boston Scientific Corporation
  • 15.7. CardiacAssist, Inc.
  • 15.8. Cook Medical LLC
  • 15.9. CorWave SA
  • 15.10. CVRx, Inc.
  • 15.11. Edwards Lifesciences Corporation
  • 15.12. Getinge AB
  • 15.13. Jarvik Heart Inc.
  • 15.14. Lepu Medical Technology Co., Ltd.
  • 15.15. LivaNova PLC
  • 15.16. MEDICO S.p.A.
  • 15.17. Medtronic plc
  • 15.18. MicroPort Scientific Corporation
  • 15.19. OSCOR Inc.
  • 15.20. Osypka Medical GmbH
  • 15.21. Otsuka Pharmaceutical Co., Ltd.
  • 15.22. ReliantHeart, Inc.
  • 15.23. Shree Pacetronix Ltd.
  • 15.24. SynCardia Systems LLC
  • 15.25. Terumo Corporation
  • 15.26. Vitatron B.V.
  • 15.27. W. L. Gore & Associates, Inc.
  • 15.28. Zoll Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIVENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL LEFT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RIGHT VENTRICULAR ASSIST DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELECTRICAL STIMULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ASYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SYNCHRONOUS PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MECHANICAL CIRCULATORY SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 105. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 106. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 108. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 110. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. GCC CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPEAN UNION CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 123. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 124. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. BRICS CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 126. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 127. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 129. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 130. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 131. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. G7 CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 136. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 137. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 138. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. NATO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 142. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 144. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 145. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 146. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. UNITED STATES CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 148. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 151. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 152. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 153. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. CANADA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 158. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 159. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 160. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MEXICO CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 163. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 165. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 166. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 167. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRAZIL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED KINGDOM CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 177. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 179. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 180. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 181. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GERMANY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 186. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 187. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 188. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. FRANCE CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 190. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 193. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 194. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 195. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. RUSSIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 197. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 200. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 201. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 202. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 203. ITALY CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 204. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 205. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 207. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 208. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 209. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. SPAIN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 221. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 222. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 223. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. INDIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 228. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 229. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 230. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. JAPAN CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 235. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 236. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 237. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. AUSTRALIA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2032 (USD MILLION)
  • TABLE 242. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY THERAPEUTIC MODALITY, 2018-2032 (USD MILLION)
  • TABLE 243. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY ELECTRICAL STIMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. SOUTH KOREA CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)